Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device.
Author Department
Medicine
Document Type
Article, Peer-reviewed
Publication Date
1-1-2005
Abstract
Distal balloon occlusion was approved as a means of embolic protection during saphenous vein graft intervention based on its ability to decrease major adverse clinical events (MACEs) by 42% in the 801-patient Saphenous Vein Graft Angioplasty Free of Embol
Publication ISSN
0195-9131
Recommended Citation
Am J Cardiol 2005 Jan 15;95(2):173-7.
COinS